Randomized Phase II Study of Consecutive-Day versus Alternate-Day Treatment with S-1 as Second-Line Chemotherapy in Advanced Pancreatic Cancer.
Ishikawa T, Kawashima H, Ohno E, Matsubara H, Sasaki Y, Achiwa K, Kanamori A, Sumi H, Hirai T, Nonogaki K, Tsuzuki T, Kuroiwa M, Hattori M, Maruta S, Hiramatsu T, Ando M, Hashimoto S, Hirooka Y.
Ishikawa T, et al. Among authors: hashimoto s.
Oncology. 2019;96(1):1-7. doi: 10.1159/000492388. Epub 2018 Oct 26.
Oncology. 2019.
PMID: 30368509
Clinical Trial.